Hypertension and coronary artery disease

Medical Clinics of North America

Volumn 81, Issue 5, 1997, Pages 1147-1163

  Srikanthan, V S ^a   Dunn, F G ^a  

^a NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ANGINA PECTORIS; CORONARY RISK; ELECTROCARDIOGRAM; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCINTIANGIOCARDIOGRAPHY; SUDDEN DEATH; TREATMENT PLANNING;

EID: 0030870468     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70572-1     Document Type: Article

References (77)

1. Acute Infarction Ramipril Efficacy (AIRE) Study Investigators Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure Lancet 342 1993 821 828
2. I. Antony E. Aptecar G. Lerebours Coronary artery constriction caused by the cold pressor test in human hypertension Hypertension 23 1994 212 219
3. I. Antony G. Lerebours G. Nitenberg Loss of flow dependent coronary artery dilatation in patients with hypertension Circulation 91 1995 1624 1628
4. E. Arbustini M. Grasso R. Fasani Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction Br Heart J 74 1995 584 591
5. I.J. Benjhamin J.E. Jalil L.B. Tan Isoproteronol induced myocardial fibrosis in relation to myocyte necrosis Circ Res 65 1989 657 670
6. Beta-Blocker Pooling Project Research Group The Beta-Blocker Pooling Project (BBPP): Subgroup findings from randomized trials in post-infarction patients Eur Heart J 9 1988 8 16
7. J.E. Brush R.O. Cannon W.H. Shenke Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy N Engl J Med 319 1988 1302 1307
8. J.E. Brush D.P. Faxon S. Salmon Abnormal endothelium-dependent coronary vasomotion in hypertensive patients J Am Coll Cardiol 19 1992 809 815
9. G.E. Burch N.P. DePasquale The anomalous left coronary artery: An experiment of nature Am J Med 37 1964 159
10. P.N. Casale R.B. Devereux M. Milner Value of echocardiographic left ventricular mass in predicting cardiovascular morbid events in hypertensive men Ann Intern Med 105 1986 1773 1778
11. R. Cassone C. Moroni O. Schillaci Clinical use of echo-dipyridamole test in hypertensive subjects with suspected ischaemic heart disease Minerva Cardioangiol 42 1994 327 332
12. M. Caulfield P. Lavender F. Martin Linkage of the angiotensin gene to essential hypertension N Engl J Med 330 1994 1629 1633
13. CIBIS Investigators and Committees A randomized trial of beta blockade in heart failure: The Cardiac Insufficiency Bisoprolol Study (CIBIS) Circulation 90 1994 1765 1773
14. B. Dahlof K. Pennert L. Hansson Reversal of left ventricular hypertrophy in hypertensive patients Am J Hypertens 5 1992 95 110
15. P. Daly J.L. Rouleau D. Cousineau Acute effects of captopril on the coronary circulation of patients with hypertension and angina Am J Med 76 1984 111 115
16. M. Davies A. Thomas Plaque fissuring—the cause of acute myocardial infarction, sudden ischaemic death and crescendo angina Br Heart J 53 1985 363 373
17. F. Dayanikli D. Grambow O. Muzik Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography Circulation 90 1994 808 817
18. V.H. DeBruyn D.W. Nuno M. Capelli-Bigazzi Effect of acute hypertension in the coronary circulation: Role of mechanical factors and oxygen radicals J Hypertens 12 1994 163 172
19. R.B. Devereux D.R. Alonso E.M. Lutas Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings Am J Cardiol 57 1986 450 458
20. R.B. Devereux M.J. Koren G. DeDeimone Methods for detection of left ventricular hypertrophy: Application to hypertensive heart disease Eur Heart J 14 suppl 1993 8 15
21. G.A. Diamond J.S. Forrester Analysis of probability as an aid in the clinical diagnosis of coronary artery disease N Engl J Med 300 1979 1350 1358
22. F.G. Dunn E.D. Frohlich Hypertension and angina pectoris Yu P. Goodwin J.F. Progress in Cardiology 1978 Lea & Febiger Philadelphia
23. F.G. Dunn J. McLenachan C.G. Isles Left ventricular hypertrophy and mortality in hypertension: An analysis of data from the Glasgow Blood Pressure Clinic J Hypertens 8 1990 775 782
24. J. Filipovsky P. Ducimetiere M.E. Safar Prognostic significance of exercise blood pressure and heart rate in middle aged men Hypertension 20 1992 333 339
25. E.D. Frohlich V.S. Kozul R.C. Tarazi Physiological comparison of labile and sustained hypertension Circ Res 26 supp1 1970 55 69
26. E.D. Frohlich R.C. Tarazi H.P. Dustan Clinical-physiological correlations in the development of hypertensive heart disease Circulation 44 1971 446 455
27. P. Gosse G. Campello E. Aouizerate Left ventricular hypertrophy in hypertension: Correlation with rest, exercise and ambulatory systolic blood pressure J Hypertens 4 suppl 5 1986 S297 S299
28. A. Hata C. Namikawa M. Sasaki Angiotensinogen as a risk factor for essential hypertension in Japan J Clin Invest 93 1994 1285 1287
29. D. Herpin J. Ferrandis B. Gaudeau Coronary artery disease in hypertensive patients: Improvement of the diagnostic value of exercise test by heart rate adjusted ST segment depression Arch Mal Coeur Vaiss 88 1995 1129 1133
30. Israel SPRINT Study Group Secondary Prevention Reinfarction Trial (SPRINT): A randomized trial of nifedipine in patients with acute myocardial infarction Eur Heart J 9 1988 354 364
31. K. Issaz J.F. Bruntz D. Paris Abnormal coronary flow velocity profile in patients with left ventricular hypertrophy, angina pectoris and normal coronary arteries: A transesophageal Doppler echocardiographic study Am Heart J 128 1994 500 510
32. M.A. James J.V. Jones Ventricular arrhythmia in untreated newly presenting hypertensive patients compared with matched normal population J Hypertens 7 1989 409 415
33. C.M. Jespersen J.F. Hansen the Danish Study Group in Verapamil in Myocardial Infarction Effect of verapamil on reinfarction and cardiovascular events in patients with arterial hypertension included in the Danish Verapamil Infarction Trial II J Hum Hypertens 8 1994 85 88
34. S. Julius Sympathetic hyperactivity and coronary risk in hypertension Hypertension 21 1993 886 893
35. K. Kamide M. Nagano N. Nakano Role of insulin resistance in cardiovascular hypertrophy in patients with essential hypertension [abstr] Am J Hypertens 8 1995 51A
36. W.B. Kannel Left ventricular hypertrophy as a risk factor in arterial hypertension Eur Heart J 13 suppl D 1992 82 88
37. W.B. Kannel A.L. Dannenberg R. Abbott Unrecognized myocardial infarction and hypertension: The Framingham study Am Heart J 109 1985 581 585
38. W.B. Kannel T. Gordon W.P. Castelli Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease: The Framingham study Ann Intern Med 72 1970 813 822
39. W.B. Kannel M.J. Schwartz P.M. McNamara Blood pressure and the risk of coronary heart disease: The Framingham study Crit Rev Dis Chest 56 1969 43
40. T. Katsuya G. Koike T.W. Yee Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease Lancet 345 1995 1600 1603
41. S. Koyanagi C.L. Eastham M.L. Marcus Effects of chronic hypertension and left ventricular hypertrophy on the incidence of sudden death after coronary artery occlusion in conscious dogs Circulation 65 1982 1192 1197
42. B.E. Kreger A. Cupples W.B. Kannel The electrocardiogram in prediction of sudden death: Framingham study experience Am Heart J 113 1987 377 382
43. D. Levy K.M. Anderson D.D. Savage Risk of ventricular arrhythmias in left ventricular hypertrophy: The Framingham Heart Study Am J Cardiol 60 1987 560 565
44. D. Levy K.A. Anderson D. Savage Echocardiographically detected left ventricular hypertrophy: Prevalence and risk factors: The Framingham study Ann Intern Med 108 1988 7 13
45. D. Levy R.J. Garrison D.D. Savage Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study N Engl J Med 322 1990 1561 1566
46. P.O. Lim R.J. MacFadyen P.B. Clarkson Impaired exercise tolerance in hypertensive patients Ann Intern Med 124 pt 1 1996 41 55
47. U. Lindblad L. Rastam Control of blood pressure and first acute myocardial infarction: Skaraborg Hypertension project BMJ 308 1994 681 686
48. M. Luque-Otero F. Perez-Casar J. Alkazar Increased ventricular arrhythmias in hypertensives with left ventricular hypertrophy J Hypertens 4 suppl 6 1986 S66 S67
49. S. MacMahon R. Peto J. Cutler Blood pressure, stroke and coronary heart disease: Part I. Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias Lancet 335 1990 765 774
50. M. Mantarri L. Tenkanen V. Mannihen Antihypertensive therapy in dyslipidemic men: Effects on coronary heart disease incidence and total mortality Hypertension 25 1995 47 52
51. B.M. Massie Y. Szlachcic J.F. Tubau Scintigraphic and electrocardiographic evidence of silent coronary artery disease in asymptomatic hypertension: A case-control study J Am Coll Cardiol 22 1993 1598 1606
52. J.M. McLenachan E. Henderson K.I. Morris Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy N Engl J Med 317 1987 787 792
53. Medical Research Council Working Party MRC trial of treatment of mild hypertension: Principal results BMJ 291 1985 97 100
54. F.H. Messerli H.O. Ventura D.J. Elizardi Hypertension and sudden death: Increased ventricular ectopic activity in left ventricular hypertrophy Am J Med 77 1984 18 22
55. A.J. Moss D. Oates M. Rubison Effects of diltiazem on long-term outcome after acute myocardial infarction in patients with and without a history of systemic hypertension Am J Cardiol 68 1991 429 433
56. G. Olsson J. Tuomilehto G. Berglund Primary prevention of sudden cardiovascular death in hypertensive patients: Mortality results from the MAPHY study Am J Hypertens 4 1991 151 158
57. V. Papademetriou M. Price A. Notargiacoma Effect of diuretic therapy on ventricular arrhythmias in hypertensive patients with or without left ventricular hypertrophy Am Heart J 110 1985 595 599
58. S. Pell C.A. D'Alonzo Immediate mortality and five year survival of employed men with a first myocardial infarction N Engl J Med 270 1964 915 922
59. M.A. Pfeffer E. Braunwald L.A. Moye Effects of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 327 1992 668 677
60. E. Picano A.R. Lucarini F. Lattanzi Dipyridamole echocardiography in essential hypertensive patients with chest pain Hypertension 12 1988 238 243
61. S.D. Pringle F.G. Dunn P.W. Macfarlane Significance of ventricular arrhythmias in systemic hypertension with left ventricular hypertrophy Am J Cardiol 69 1992 913 917
62. S.D. Pringle F.G. Dunn A.C. Tweddel Symptomatic and silent myocardial ischaemia in hypertensive patients with left ventricular hypertrophy Br Heart J 67 1992 377 382
63. H. Rakugi H. Yu A. Kamitany Links between hypertension and myocardial infarction Am Heart J 132 1996 213 221
64. S.J. Sarnoff E. Braunwald Welch G.H. Jr Hemodynamic determinants of oxygen consumption of the heart with special reference to the tension-time index Am J Physiol 192 1958 148
65. S. Scheler W. Motz B.W. Strauer Mechanism of angina pectoris in patients with systemic hypertension and normal epicardial coronary arteries by angiogram Am J Cardiol 73 1994 478 482
66. SHEP Cooperative Research Group Prevention of stroke by anti hypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP) JAMA 265 1991 3255 3264
67. J. Shepherd S.M. Cobbe I. Ford Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia N Engl J Med 333 1993 1301 1307
68. D.S. Sheps J.C. Ernst F.W. Briese Exercise induced increase in diastolic pressure: Indication of severe coronary artery disease Am J Cardiol 43 1979 708 712
69. E. Sigurdsson N. Sigfusson H. Sigvaldason Silent ST-T changes in an epidemiological cohort study—a marker of hypertension or coronary heart disease, or both: The Reykjavik Study J Am Coll Cardiol 27 1996 1140 1147
70. SOLVD Investigators Effects of enalapril on survival of patients with reduced left ventricular ejection fraction and congestive heart failure N Engl J Med 325 1991 293 302
71. J.R. Sowers P.R. Standley J.L. Ram Hyperinsulinemia, insulin resistance, and hyperglycemia: Contributing factors in the pathogenesis of hypertension and atherosclerosis Am J Hypertens 6 1993 260s 270s
72. C.R. Spillert S. Sun M.A. Miller Hypertension related coronary thrombosis: Prothrombotic role of angiotensin II J Natl Med Assoc 86 1994 686 688
73. K. Swedberg P. Held Kjekshus J. on behalf of the CONSENSUS II study group Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction: Results of the cooperative new Scandinavian Enalapril survival study (CONSENSUS II) N Engl J Med 327 1992 678 684
74. J.F. Tubau J. Szlachcic M. Hollenberg Usefulness of thallium-201 scintigraphy in predicting the development of angina pectoris in hypertensive patients with left ventricular hypertrophy Am J Cardiol 64 1989 45 49
75. C.J. Vaughan M.B. Murphy B.M. Buckley Statins do more than just lower cholesterol Lancet 348 1996 1079 1082
76. D.R. Wallbridge S.M. Cobbe Coronary haemodynamics in left ventricular hypertrophy Heart 75 1996 369 376
77. J.B. Young Reduction of ischemic events with angiotensin-converting enzyme inhibitors: Lessons and controversy emerging from recent clinical trials Cardiovasc Drugs Ther 9 1995 89 102